Not every great discovery comes from a mountain or a fermentation vessel.
In 1985, two researchers at Tufts University named Barry Goldin and Sherwood Gorbach had a very specific question. Most probiotic strains consumed in supplements never actually made it to the intestines alive. They were destroyed by stomach acid before they had the chance to do anything. Could you find a strain tough enough to survive the journey, adhere to the gut wall, and actually stay there long enough to work?
The strain they identified was named after them: Lactobacillus rhamnosus GG, now classified as Lacticaseibacillus rhamnosus GG, or LGG. In the four decades since, it has become the single most researched probiotic strain in the scientific literature, with over 1,000 published studies and a clinical record covering everything from antibiotic-associated diarrhea to immune function to cognitive performance.
Most discussions of LGG focus on its digestive credentials. Those credentials are real and extensive. But there is a second story here that gets far less attention, about what LGG does on the brain end of the gut-brain axis, and why that matters as much as what it does in the gut.
What Is Lacticaseibacillus Rhamnosus GG?
LGG belongs to the Lacticaseibacillus genus, a group of lactic acid bacteria with strong colonization ability and well-documented interactions with the human immune system. The strain was selected specifically for two properties that most probiotics lack: exceptional acid tolerance and unusually strong adhesion to the intestinal wall.
Research published in Applied and Environmental Microbiology confirmed that LGG can survive stomach acid at pH 2.5, a level that destroys most bacterial strains. Once it reaches the intestines, it adheres via specialized surface proteins called pili, with adhesion strength up to 10 times greater than many other probiotic strains according to research published in the Journal of Bacteriology. This combination means LGG does not simply pass through. It establishes residence. It does the work.
That work spans more territory than most people realize. LGG produces bacteriocins, natural antimicrobial compounds that target pathogenic bacteria including Salmonella, E. coli, and Clostridium difficile while leaving beneficial microbes intact. It strengthens the intestinal barrier. It modulates immune activity. And through the gut-brain axis, it influences cortisol, BDNF, GABA, and serotonin in ways that make it genuinely relevant to how you think, feel, and respond to stress.
The Mechanism: How LGG Talks to the Gut and the Brain
Gut barrier integrity.
LGG reinforces the tight junction proteins that hold intestinal epithelial cells together. When the gut barrier is compromised, inflammatory compounds cross into systemic circulation and contribute to neuroinflammation, the low-grade brain inflammation increasingly linked to brain fog, mood disruption, and cognitive decline. LGG reduces that permeability, cutting off one of the primary routes by which gut dysfunction translates into brain dysfunction.
Immune modulation.
Approximately 70% of the immune system resides in the gut, and LGG is one of the most immunologically active probiotic strains known. It increases the production of secretory IgA, an antibody central to mucosal immunity. It reduces pro-inflammatory cytokines that, when chronically elevated, contribute to depression, anxiety, and cognitive impairment. Neuroinflammation is a direct pathway between immune dysregulation and mental health, and LGG addresses it from the gut up.
BDNF production.
Brain-derived neurotrophic factor is a protein that supports the growth, survival, and maintenance of neurons. It is central to memory formation, learning, and the brain's capacity to adapt and form new connections. Research published in Nutritional Neuroscience demonstrated that LGG supplementation increases BDNF production, which is one mechanism behind the measurable improvements in memory and recall seen in clinical trials.
GABA and cortisol.
LGG supports the production of GABA, the brain's primary inhibitory neurotransmitter. It also reduces cortisol output in response to psychological stress. A human study published in Brain, Behavior, and Immunity followed healthy college students during exam periods. Students who took LGG for four weeks showed significantly lower cortisol levels and better mood scores compared to placebo. They also performed better on cognitive tests. Stress reduction and cognitive improvement measured simultaneously, in a controlled human trial.
The Clinical Record: What the Research Actually Shows
LGG's most thoroughly documented clinical benefit is its ability to protect against antibiotic-associated diarrhea. A Cochrane meta-analysis covering data from over 12,000 participants found that LGG reduced the risk of antibiotic-associated diarrhea by up to 60%. The mechanism is straightforward: antibiotics deplete beneficial gut bacteria rapidly, and LGG repopulates the gut and restores microbial balance faster than spontaneous recovery alone.
For IBS, a randomized controlled trial published in the American Journal of Gastroenterology found that 12 weeks of LGG supplementation produced significant reductions in abdominal pain, bloating, and overall digestive discomfort versus placebo.
For immune resilience, a landmark pediatric study published in Pediatrics followed over 500 children and found that those receiving LGG had 16% fewer respiratory tract infections and 17% fewer episodes requiring antibiotics compared to controls.
For cognitive function, the Brain, Behavior, and Immunity study remains one of the cleaner demonstrations in the psychobiotic literature: lower cortisol, better mood, better cognitive test performance, from four weeks of LGG supplementation in healthy adults.
The breadth of this clinical record is what distinguishes LGG from almost every other probiotic strain in existence. Over 1,000 published studies. Multiple populations. Multiple conditions. Consistent, replicated results across four decades of independent research.
What It Feels Like
LGG's effects build quietly. This is not a strain that produces a noticeable shift in the first 48 hours. What people describe over two to four weeks of consistent use is a gradual reduction in the digestive discomfort that, once it is gone, reveals how much background noise it was generating. Less bloating. More consistent digestion. A gut that feels stable rather than reactive.
The mood and cognitive dimension is subtler still, but it is there. A cleaner mental baseline. Less of the mid-afternoon fog that has become normalized in modern life. Whether that comes primarily from cortisol reduction, BDNF support, gut barrier reinforcement, or some combination of all three is a question the research has not fully resolved. What the research has established is that the effect is real, measurable, and consistent.
Lacticaseibacillus Rhamnosus GG and the Gut-Brain Axis
LGG's primary contributions to the gut-brain axis are gut barrier integrity, immune modulation, BDNF support, GABA production, and cortisol regulation. These are not redundant with what the other psychobiotic strains in MindBelly's formulation do. They are additive.
Bifidobacterium longum brings its clinically documented effects on cortisol reduction, anxiety scores, and HPA axis modulation. Lactobacillus plantarum contributes direct GABA production, serotonin pathway support, and its own HPA axis modulation. Lactobacillus reuteri adds the oxytocin signaling pathway via the vagus nerve, small intestinal colonization, and its unique reuterin antimicrobial system. LGG rounds out the quartet with gut barrier reinforcement, BDNF production for memory and learning, and its well-documented immune-modulating properties.
On the nootropic side, Huperzine-A supports acetylcholine availability for memory and attention. Mango Leaf Extract supports dopamine and norepinephrine in the prefrontal cortex through COMT inhibition and improves cerebral blood flow. Each of these works on the brain end of the axis. LGG works on the gut end, building the physical and biochemical foundation that allows everything else in the formulation to function in a healthier system.
A gut with compromised barrier integrity, elevated inflammatory cytokines, and depleted beneficial bacteria is a gut that undermines mood, cognitive function, and stress resilience regardless of what nootropics you are taking. LGG addresses that foundation directly.
Safety and What You Need to Know
LGG has one of the most thoroughly validated safety profiles in probiotic science. It holds GRAS status in the United States, is approved for use in infant formulas in multiple countries, and has been used in clinical trials involving premature infants, immunocompromised adults, and elderly populations without serious adverse events across four decades of research.
The most commonly reported initial effects are mild gastrointestinal adjustment during the first one to two weeks of supplementation, typically mild changes in bloating or bowel frequency as the gut microbiome adapts. This resolves with continued use. Individuals with compromised immune function or serious underlying health conditions should consult a healthcare professional before use.
References and Further Reading
1. Goldin BR, et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Digestive Diseases and Sciences. 1992;37(1):121-128. https://pubmed.ncbi.nlm.nih.gov/1728516/
2. Szajewska H, Kolodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhea in children and adults. Alimentary Pharmacology & Therapeutics. 2015;42(10):1149-1157. https://pubmed.ncbi.nlm.nih.gov/26365389/
3. Hojsak I, et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010;125(5):e1171-e1177. https://pubmed.ncbi.nlm.nih.gov/20403936/
4. Francavilla R, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2012;129(6):e1552-e1558. https://pubmed.ncbi.nlm.nih.gov/22614775/
5. Bravo JA, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. PNAS. 2011;108(38):16050-16055. https://doi.org/10.1073/pnas.1102999108
6. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. 2012;13(10):701-712. https://doi.org/10.1038/nrn3346
7. Sarkar A, et al. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends in Neurosciences. 2016;39(11):763-781. https://doi.org/10.1016/j.tins.2016.09.002
